cetylpyridinium chloride anhydrous has been researched along with Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, A; Enriquez, J; Liao, L; Maher, L; Park, JN; White, B | 1 |
| Andreoli, E; Bendinelli, M; Maggi, F; Meschi, S; Nelli, LC; Pistello, M; Vatteroni, M | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Hepatitis C
| Article | Year |
|---|---|
Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
Topics: Adult; Altruism; Cohort Studies; Fear; Female; Health; Health Knowledge, Attitudes, Practice; Hepacivirus; Hepatitis C; Humans; Male; Motivation; New South Wales; Patient Education as Topic; Research Subjects; Risk; Safety; Substance Abuse, Intravenous; Viral Vaccines; Young Adult | 2012 |
Small Anellovirus in hepatitis C patients and healthy controls.
Topics: Adult; Aged; Case-Control Studies; DNA Virus Infections; Female; Genetic Variation; Health; Hepatitis C; Humans; Male; Middle Aged; Torque teno virus | 2006 |